Join to view full profile
600 Gresham Drive,Dept Of PathologyNorfolk, VA 23507
Phone+1 757-388-3488
Fax+1 757-388-3799
Join Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 3 invites waiting! - Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Suhail Nasim, MD is a board certified pathologist in Norfolk, Virginia. He is currently licensed to practice medicine in Virginia and North Carolina. He is affiliated with Sentara Northern Virginia Medical Center.
Education & Training
Virginia Commonwealth University Health SystemResidency, Pathology-Anatomic and Clinical, 1993 - 1997
University of Virginia School of MedicineClass of 1997
George Washington University School of MedicineInternship, Transitional Year, 1992 - 1993
Allama Iqbal Medical CollegeClass of 1982
Certifications & Licensure
VA State Medical License 1997 - 2028
NC State Medical License 2016 - 2027
American Board of Pathology Anatomic Pathology & Clinical Pathology- American Board of Pathology Molecular Genetic Pathology
Publications & Presentations
PubMed
- 85 citationsEvaluation of Quality-Control Criteria for Microarray Gene Expression AnalysisCatherine I. Dumur, Suhail Nasim, Al M. Best, Kellie J. Archer, Amy C. Ladd
Clinical Chemistry. 2004-11-01 - 27 citationsEvaluation of a linear amplification method for small samples used on high-density oligonucleotide microarray analysis.Catherine I. Dumur, Carleton T. Garrett, Kellie J. Archer, Suhail Nasim, David S. Wilkinson
Analytical Biochemistry. 2004-08-15 - 129 citationsNormal, benign, preneoplastic, and malignant prostate cells have distinct protein expression profiles resolved by surface enhanced laser desorption/ionization mass spe...Lisa H. Cazares, Bao Ling Adam, Michael D. Ward, Suhail Nasim, Paul F. Schellhammer
Clinical Cancer Research. 2002-08-01